Nicole Balmaceda MD (She/Her)

PubMed

• Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non-small-cell lung cancer.
  Kibum Kim, Sakil Syeed, Trang Au, Amber Diaz, Matthew B Schabath
  Cancer Treatment and Research Communications. 2025-03-13
• 1 citations
  Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma.
  Nicole Baranda Balmaceda, Sunnie S Kim
  Current Oncology Reports. 2025-02-01
• Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
  Aleksander Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley
  Annals of Hematology. 2024-08-01

Journal Articles

• State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care  
  Nicole Balmaceda, American Society of Clinical Oncology Educational Book, 5/21/2024
• Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study  
  Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bod..., eLife, 10/17/2023
• Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19  
  Ziad Bakouny, MD; Chris Labaki, MD; Punita Grover, MD; et al, JAMA Oncology, 11/3/2022
• Hematologic Malignancies in Temozolomide-Treated Metastatic Pancreatic Neuroendocrine Tumors  
  Nicole Balmaceda*, Tyler Mouw, Sunil Abhyankar, Heather Male, Janet Woodroof and Joaquina Baranda, EC Gastroenterology and Digestive System, 3/3/2020
• The prognosis of NF1 mutations in newly diagnosed AML: A single-center retrospective study  
  Mohammad Telfah, Haitham Abdelhakim, Nicole Balmaceda, Eyad Gharaibeh, Andrew K. Godwin, Ziyan Y. Pessetto, Joseph McGuirk, and Tara L. Lin, Journal of Clinical Oncology, 5/26/2019
• Esophageal Cancer: Current and Evolving Treatment Landscape. J Surg 12: 1220. DOI: 10.29011/2575-9760.001220  
  Balmaceda NB, Baranda JC, DiPasco P, Sun W, John Ashcraft J, et al., Journal of Surgery, 5/2019
• Secondary malignancies in temozolomide-treated metastatic pancreatic neuroendocrine tumors  
  Balmaceda N, Abhyankar S, Mouw T, Baranda J., Cancer Research, 2018
• Join now to see all

Abstracts/Posters

• The association of antibiotic use and survival among patients receiving first line immunotherapy-based treatment for advanced gastroesophageal cancers
  Nicole Balmaceda, Sunnie Kim, Journal of Clinical Oncology, ASCO GI, 1/23/2025
• Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib.
  Aleksander Lech Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley, Tommy Chen, Rupali Bose, Nikolai Alexandrovich Podoltsev, Amer Methqal Z..., Journal of Clinical Oncology , 2023 ASCO, 6/1/2023